由营养风险查指导的连续营养干预改善了胰腺癌的CyberKnife放射治疗后的结果:一项随机对照试验
Feifei Wang1, Liwei Zhang1, Na Li1
1Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
概括
顺序营养干预改善了接受CyberKnife放射治疗的胰腺癌患者的营养状况,免疫功能和生活质量. 这种方法还减少了术后并发症,显示了临床价值.
科学领域:
- 在瘤学瘤学.
- 营养科学 营养科学
- 辐射疗法 辐射疗法
背景情况:
- 营养状况显著影响胰腺癌患者的治疗结果.
- 网络刀辐射疗法是胰腺癌的治疗选择.
研究的目的:
- 以营养风险查为指导的顺序营养干预措施的有效性进行评估.
- 为了评估对营养状况,免疫功能,生活质量 (QoL) 和手术后并发症的影响,在接受CyberKnife放射治疗胰腺癌的患者中.
主要方法:
- 100名胰腺癌患者被随机分配到对照组 (n=50) 和营养干预组 (n=50).
- 营养状况,免疫标志物 (免疫球蛋白,T细胞子集),QoL和并发症在基线,干预后1周和1个月被评估.
主要成果:
- 与干预后的对照组相比,营养干预组的营养指标 (TP,TRF,ALB,PA) 和免疫标志物 (IgA,IgM,IgG,CD3+,CD4+,CD8+) 显著改善.
- 生活质量得分显著改善,营养干预组的整体并发症发生率较低.
- 在干预后的两组之间,CD4+/CD8+比率没有显著差异.
结论:
- 由营养风险查指导的连续营养干预对接受CyberKnife放射治疗的胰腺癌患者有效.
- 这种干预可以提高营养状况,免疫功能和质量.
- 该方法还导致手术后并发症的减少,支持其临床应用.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
284
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
284
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
420
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455


